DAYMARK WEALTH PARTNERS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1956824 CINCINNATI, OH

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$3,859,181

-$473,135 QoQ

Shares Held

30,546

-1.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#645

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAYMARK WEALTH PARTNERS, LLC holds $218,773,359 across 12 Drug Manufacturers - General names. GILD ranks #9 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	266,410	$67,660,147
2	AMGN	Amgen Inc	150,438	$54,476,608
3	ABBV	AbbVie Inc.	130,459	$32,828,702
4	LLY	ELI LILLY & Co	25,552	$30,647,837
5	MRK	Merck & Co., Inc.	81,443	$10,465,425
6	NVS	Novartis AG	43,852	$6,872,485
7	BMY	Bristol Myers Squibb Co	85,038	$4,899,889
8	PFE	Pfizer Inc	173,196	$4,170,559

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,859,181	30,546	-1.7%	Shares	Sole	2026-07-31
2026-03-31	$4,332,316	31,085	-2.6%	Shares	Sole	2026-05-11
2025-12-31	$3,916,510	31,909	+2.4%	Shares	Sole	2026-01-12
2025-09-30	$3,460,314	31,174	+7.3%	Shares	Sole	2025-10-22
2025-06-30	$3,221,882	29,060	+0.1%	Shares	Sole	2025-08-04
2025-03-31	$3,253,371	29,035	-6.0%	Shares	Sole	2025-04-23
2024-12-31	$2,853,309	30,890	-0.7%	Shares	Sole	2025-01-17
2024-09-30	$2,607,507	31,101	-0.0%	Shares	Sole	2024-10-08
2024-06-30	$2,134,114	31,105	-17.3%	Shares	Sole	2024-08-14
2024-03-31	$2,755,884	37,623	+0.1%	Shares	Sole	2024-04-10
2023-12-31	$3,046,300	37,604	+13.9%	Shares	Sole	2024-01-09
2023-09-30	$2,475,043	33,027	+26.2%	Shares	Sole	2023-10-10
2023-06-30	$2,017,153	26,173	+37.6%	Shares	Sole	2023-07-19
2023-03-31	$1,578,421	19,024	+2.8%	Shares	Sole	2023-04-20
2022-12-31	$1,588,310	18,501	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.